Navigation Links
Early Menstruation Lowers Odds of Surviving Ovarian Cancer
Date:7/9/2009

Patients who had first period before age 12 are at increased risk of death, study shows

THURSDAY, July 9 (HealthDay News) -- Among women with ovarian cancer, those who had their first menstrual period before the age of 12 and who had the most menstrual cycles over a lifetime are more likely to die of the cancer than those who had fewer ovulatory cycles, a new study shows.

U.S. researchers analyzed data on 410 women, aged 20 to 54, who had ovarian cancer and were enrolled in the Cancer and Steroid Hormone (CASH) study between 1980 and 1982.

Using data that included in-depth patient interviews, reproductive history, contraceptive use and personal and family medical history, the researchers divided the women into groups based on their total number of ovulatory cycles.

There were 212 deaths among the participants during a median follow-up of 9.2 years, the study authors noted.

Women in the group who had the highest number of lifetime ovulatory cycles had a 67 percent greater chance of dying during the study follow-up, which ranged up to about 17 years.

The findings were independent of a woman's age at the time of the study, which would of course have a significant impact on the number of menstrual cycles a woman had had, said study author Cheryl Robbins, an epidemiologist at the U.S. Centers for Disease Control and Prevention.

Ovarian cancer patients whose age at menarche, or first menstrual cycle, was younger than 12 were 51 percent more likely to die from the cancer than those whose age at menarche was 14 or older, according to the study, published in the July issue of Cancer Epidemiology, Biomarkers & Prevention.

Ovarian cancer is the fifth-leading cause of cancer deaths among women. The high mortality is due, in part, because the disease is typically discovered after it has spread. Only about one-fifth of ovarian cancers are detected when the cancer is still localized, the study authors noted.

Previous research has linked age at first menstrual period and number of lifetime menstrual cycles with the risk of ovarian cancer, while use of oral contraceptives and hysterectomy or tubal ligation, which halt ovulation, have also been shown to reduce the risk of developing ovarian cancer.

Other studies have also found that having children earlier in life, having multiple children and breast-feeding provide protection, but the results are inconsistent, the researchers noted.

But less is known about the impact of those hormonal and reproductive factors on survival rates for women who already have the cancer.

"Although we have relatively good knowledge about the influence of reproductive factors on the risk of developing ovarian cancer, knowledge is rather limited regarding the reproductive factors that may influence survival after diagnosis with this serious disease," Robbins said.

Though the exact mechanism isn't understood, researchers believe that the surge of hormones brought on by ovulation, or the insult to the cells that occurs during ovulation, may be associated with more aggressive tumors, Robbins said.

In the current study, while age at first period and total lifetime menstrual cycles impacted survival, other factors, including number of pregnancies, breast-feeding and menopausal status did not show a statistically significant impact on survival rates.

Dr. Mary B. Daly, director of the Personalized Cancer Risk Assessment Program at the Fox Chase Cancer Center in Philadelphia, said the results shed more light on the role reproductive hormones play in ovarian cancer, potentially providing clues for developing new treatments for aggressive cancers.

Yet the study has its limitations, Daly added. Women's recollections could have been flawed, and the study participants were younger than the typical ovarian cancer patient and so may not be truly representative. Additionally, the women in the study had ovarian cancer nearly 30 years ago and would not have been receiving today's more advanced chemotherapy treatments.

Nor is the research definitive enough to suggest that women should go out and start taking contraceptive pills or having babies earlier to increase their chances of surviving ovarian cancer.

"The paper may suggest other avenues of research into what is it about the hormonal profile of women that could affect the biology of their ovarian cancer," Daly said. "As of right now, it doesn't translate into something you could clinically do differently."

More information

The U.S. National Cancer Institute has more on ovarian cancer.



SOURCES: Cheryl L. Robbins, Ph.D., epidemiologist, U.S. Centers for Disease Control and Prevention, Atlanta; Mary B. Daly, M.D., Ph.D., director, Personalized Cancer Risk Assessment Program, Fox Chase Cancer Center, Philadelphia; July 2009 Cancer Epidemiology, Biomarkers & Prevention


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UT Southwestern researcher named HHMI Early Career Physician-Scientist
2. Operation for aneurysm yields nearly normal longevity
3. Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention
4. JNCI news brief: Improving the biomarker pipeline for early cancer detection
5. Study Casts Doubt on Low IQs Role in Early Death
6. Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List
7. Boston Heart Lab Named Most Promising Early Stage Company 2009 by Silicom Ventures
8. Mental Health Parity Act Spurs Early Action Among Employers
9. Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018
10. Too Few Americans Get HIV Test Early Enough
11. Being overweight, obese during early adulthood associated with greater risk of pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early Menstruation Lowers Odds of Surviving Ovarian Cancer 
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to ... and other developmental disabilities. The group, which is being launched with the help of ... to share stories and advice, seek help, and continue their education on how to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... announce that we have been designated as a Cigna Infertility Center of Excellence. ... rigorous performance standards. , “It’s an honor to be designated a Cigna ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
Breaking Medicine Technology: